These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8500773)
1. Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria. Piddock LJ; Marshall AJ; Jin YF Antimicrob Agents Chemother; 1994 Mar; 38(3):422-7. PubMed ID: 8203834 [TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolones: how to use (but not overuse) these antibiotics. Sable CA; Scheld WM Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773 [TBL] [Abstract][Full Text] [Related]
3. Prescribing considerations in fluoroquinolone therapy. Gentry LO Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937 [TBL] [Abstract][Full Text] [Related]
4. The role of the fluoroquinolones. Guay DR Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones. Hendershot EF Infect Dis Clin North Am; 1995 Sep; 9(3):715-30. PubMed ID: 7490440 [TBL] [Abstract][Full Text] [Related]
6. Tigecycline: first of a new class of antimicrobial agents. Rose WE; Rybak MJ Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [TBL] [Abstract][Full Text] [Related]
7. The fluoroquinolones for urinary tract infections: a review. Cunha BA Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268 [TBL] [Abstract][Full Text] [Related]